1 – 10 of 27
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Biomarker testing in MCI patients—deciding who to test
van Maurik, Ingrid S. ; Rhodius-Meester, Hanneke F.M. ; Teunissen, Charlotte E. ; Scheltens, Philip ; Barkhof, Frederik ; Palmqvist, Sebastian LU
; Hansson, Oskar
LU
; van der Flier, Wiesje M.
and Berkhof, Johannes
(2021)
In Alzheimer's Research and Therapy
13(1).
Mark
- Strategies to reduce sample sizes in Alzheimer’s disease primary and secondary prevention trials using longitudinal amyloid PET imaging
- The bvFTD phenocopy syndrome : a case study supported by repeated MRI, [18F]FDG-PET and pathological assessment
- Differential patterns of gray matter volumes and associated gene expression profiles in cognitively-defined Alzheimer's disease subgroups
- In vivo tau pathology is associated with synaptic loss and altered synaptic function
- 2020
- Why Is Amyloid-β PET Requested After Performing CSF Biomarkers?
- A clinical-radiological framework of the right temporal variant of frontotemporal dementia
- Comorbid amyloid-β pathology affects clinical and imaging features in VCD
- Investigating the clinico-anatomical dissociation in the behavioral variant of Alzheimer disease
- Latent atrophy factors related to phenotypical variants of posterior cortical atrophy